Nodal-Region Sparing Short-Course RT With Chemo-PD-1/Bevacizumab vs. Short-Course RT With Chemotherapy as TNT in pMMR/MSS Locally Advanced Rectal Cancer

Clinical trial NCT07674732 · RECRUITING

Trial details

NCT number: NCT07674732
Sponsor: Dechang Diao
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Short-course Radiotherapy Plus Chemotherapy Nodal-Region Sparing Short-Course Radiotherapy Followed by Sequential Chemotherapy With PD-1 Monoclonal Antibody and Bevacizumab

Start date: 2026-06-24
Primary completion: 2029-06-24
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.